AssetMark Inc’s Globus Medical GMED Stock Holding History

AssetMark Inc’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Buy	2,131 +795	+60%	+$67.6K	﹤0.01%	1489
2026 Q1	$115K	Buy	1,336 +27	+2%	+$2.42K	﹤0.01%	1496
2025 Q4	$114K	Sell	1,309 -5	-0.4%	-$380	﹤0.01%	1454
2025 Q3	$75.3K	Sell	1,314 -10,459	-89%	-$602K	﹤0.01%	1514
2025 Q2	$695K	Sell	11,773 -227	-2%	-$14.7K	﹤0.01%	990
2025 Q1	$878K	Buy	12,000 +11,105	+1,241%	+$918K	﹤0.01%	886
2024 Q4	$74K	Buy	895 +11	+1%	+$868	﹤0.01%	1312
2024 Q3	$63.2K	Buy	884 +19	+2%	+$1.34K	﹤0.01%	1232
2024 Q2	$59.2K	Hold	865	–	–	﹤0.01%	1200
2024 Q1	$46.4K	Sell	865 -4	-0.5%	-$215	﹤0.01%	1178
2023 Q4	$46.3K	Buy	869 +4	+0.5%	+$195	﹤0.01%	1179
2023 Q3	$42.9K	Hold	865	–	–	﹤0.01%	1124
2023 Q2	$51.5K	Hold	865	–	–	﹤0.01%	1071
2023 Q1	$49K	Sell	865 -5	-0.6%	-$321	﹤0.01%	1037
2022 Q4	$64.6K	Hold	870	–	–	﹤0.01%	986
2022 Q3	$52K	Hold	870	–	–	﹤0.01%	928
2022 Q2	$49K	Sell	870 -200	-19%	-$13.1K	﹤0.01%	917
2022 Q1	$79K	Hold	1,070	–	–	﹤0.01%	822
2021 Q4	$77K	Hold	1,070	–	–	﹤0.01%	827
2021 Q3	$82K	Hold	1,070	–	–	﹤0.01%	683
2021 Q2	$83K	Hold	1,070	–	–	﹤0.01%	661
2021 Q1	$66K	Hold	1,070	–	–	﹤0.01%	688
2020 Q4	$70K	Hold	1,070	–	–	﹤0.01%	653
2020 Q3	$53K	Hold	1,070	–	–	﹤0.01%	662
2020 Q2	$51K	Sell	1,070 -275	-20%	-$13.3K	﹤0.01%	649
2020 Q1	$57K	Sell	1,345 -300	-18%	-$14.8K	﹤0.01%	663
2019 Q4	$97K	Hold	1,645	–	–	﹤0.01%	631
2019 Q3	$84K	Buy	1,645 +330	+25%	+$15.7K	﹤0.01%	636
2019 Q2	$56K	Hold	1,315	–	–	﹤0.01%	680
2019 Q1	$65K	Hold	1,315	–	–	﹤0.01%	655
2018 Q4	$57K	Sell	1,315 -125	-9%	-$6.24K	﹤0.01%	659
2018 Q3	$82K	Hold	1,440	–	–	﹤0.01%	630
2018 Q2	$73K	Hold	1,440	–	–	﹤0.01%	640
2018 Q1	$72K	Sell	1,440 -120	-8%	-$5.64K	﹤0.01%	647
2017 Q4	$64K	Hold	1,560	–	–	﹤0.01%	710
2017 Q3	$46K	Hold	1,560	–	–	﹤0.01%	721
2017 Q2	$52K	Hold	1,560	–	–	﹤0.01%	672
2017 Q1	$46K	Hold	1,560	–	–	﹤0.01%	661
2016 Q4	$39K	Hold	1,560	–	–	﹤0.01%	685
2016 Q3	$35K	Sell	1,560 -261	-14%	-$6.13K	﹤0.01%	714
2016 Q2	$43K	Buy	1,821 +304	+20%	+$7.29K	﹤0.01%	635
2016 Q1	$36K	Buy	1,517 +91	+6%	+$2.23K	﹤0.01%	635
2015 Q4	$40K	Buy	+1,426	New	+$35.8K	﹤0.01%	664

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AssetMark Inc's GMED Position: Q2 2026 in Review

AssetMark Inc increased its Globus Medical (GMED) stake by 60% in Q2 2026, buying an estimated $67.6K and bringing the position to 2,131 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

AssetMark Inc first reported a position in GMED in Q4 2015 and has held it in 43 quarters since. The position peaked at $878K in Q1 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

AssetMark Inc held 2,131 shares of Globus Medical worth $168K as of Q2 2026.
AssetMark Inc bought 795 Globus Medical shares in Q2 2026, an estimated $67.6K.
Globus Medical made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1489 holding.
AssetMark Inc first reported a position in Globus Medical in Q4 2015 and has held it in 43 quarters since.
AssetMark Inc's Globus Medical position peaked at $878K in Q1 2025.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.